Product Description

Equisolon Oral Powder is indicated for the alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction (RAO) in horses, in combination with environmental control. Corticosteroid treatment should only be initiated when satisfactory alleviation of clinical symptoms has not been obtained, or is unlikely to be obtained, by environmental control alone.

For Horses:

Alleviation of inflammatory and clinical parameters associated with recurrent airway obstruction (RAO)

Used in combination with environmental management to reduce airway inflammation and associated respiratory signs

Which Animals Can Use Equisolon Oral Powder?

Equisolon Oral Powder is licensed for use in horses only. It must not be used in horses that are pregnant, or in animals suffering from diabetes mellitus, gastrointestinal ulcers, corneal ulcers, renal insufficiency, cardiac insufficiency, hyperadrenocorticism, or osteoporosis. Always use only under the direction of your vet.

Available Strengths & Sizes

Please order the specific strength and pack size as directed on your veterinary prescription.

Directions for Use

This is a prescription medication and must be used exactly as directed by your veterinary surgeon. Dosage will depend on the horse's body weight and the condition being treated. The correct dose should be mixed into a small amount of food immediately before feeding. Refer to the dispensing label or product datasheet for full dosing instructions and the dosing table provided.

Contraindications

Source: SPC Section 3.3

Do not use in cases of known hypersensitivity to prednisolone, to corticosteroids, or to any of the excipients (including lactose monohydrate, anise aroma powder, or silica colloidal hydrated)

Do not use in horses with viral infections during the viraemic stage

Do not use in cases of systemic mycotic (fungal) infections

Do not use in animals suffering from gastrointestinal ulcers

Do not use in animals suffering from corneal ulcers

Do not use during pregnancy (at any stage)

Storage & Handling

Store in the original container with the jar tightly closed. No specific temperature restriction is stated; store as per label instructions. Shelf life after first opening: 4 weeks. Once mixed into food, use within 24 hours; discard any uneaten medicated food after this period. Keep out of reach of children and animals at all times.

Withdrawal period — Meat and offal: 10 days. Not authorised for use in mares producing milk for human consumption.

Important Warnings

Source: SPC Sections 3.4 & 3.5

Use of corticosteroids in horses has been reported to induce laminitis; horses should be monitored frequently throughout the treatment period

Corticosteroid treatment is intended to improve clinical signs, not to resolve the underlying condition; environmental control must be maintained alongside treatment

Do not use in animals suffering from diabetes mellitus, renal insufficiency, cardiac insufficiency, hyperadrenocorticism, or osteoporosis

Use with caution in animals with a weakened immune system due to the pharmacological properties of prednisolone

Long-term use may lead to serious adverse effects including adrenocortical suppression; dosage in medium to long-term use should be kept to the minimum necessary to control symptoms

Following cessation of treatment, signs of adrenal insufficiency may arise; the animal may be unable to respond adequately to stressful situations

Concomitant use with NSAIDs (non-steroidal anti-inflammatory drugs) may exacerbate gastrointestinal ulceration

Do not use in combination with vaccines, or within two weeks of vaccination, as corticosteroids can reduce the immune response to vaccination

Prednisolone may induce hypokalaemia, increasing the risk of toxicity from cardiac glycosides; risk is increased if used alongside potassium-depleting diuretics

Human safety: People with known hypersensitivity to corticosteroids or any excipient must not handle this product

Human safety: Pregnant women must not administer this product due to the risk of foetal malformation

Human safety: Wear gloves and a protective respiratory mask when handling and administering the product

Human safety: Do not shake the container — to prevent dust formation and inhalation risk

In case of accidental human ingestion or exposure, seek medical advice immediately and show the product label to the treating clinician

POM-V Prescription Notice

This product is a Prescription Only Medicine — Veterinary (POM-V). It may only be supplied by a veterinary surgeon or, when prescribed by a veterinary surgeon, by a pharmacist or SQP. A valid veterinary prescription is required before this product can be dispensed.

MA Number: Vm 19994/5002 (Source: VMD Product Information Database — SPC issued December 2025, AN: 03126/2024)